PUBLISHER: The Business Research Company | PRODUCT CODE: 1666477
PUBLISHER: The Business Research Company | PRODUCT CODE: 1666477
CBD (cannabidiol) nutraceuticals encompass non-psychoactive compounds derived from cannabis plants that offer health benefits beyond basic nutritional value found in foods. CBD contains essential nutritional components such as B-complex vitamins such as Vitamin B6, B12, riboflavin, niacin, and thiamine.
The primary types of CBD nutraceutical products available include CBD tinctures, capsules and soft gels, CBD-infused proteins, and CBD gummies. CBD tinctures are liquid extracts containing cannabidiol (CBD) as the active ingredient, often dissolved in alcohol or oil mediums. These products are distributed through various channels including retail stores, pharmacies, e-commerce platforms, and others, and find application in wellness, workout supplements, edibles, and fortified foods, among other uses.
The CBD nutraceuticals market research report is one of a series of new reports from The Business Research Company that provides CBD nutraceuticals market statistics, including CBD nutraceuticals industry global market size, regional shares, competitors with a CBD nutraceuticals market share, detailed CBD nutraceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the CBD nutraceuticals industry. This CBD nutraceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The CBD nutraceuticals market size has grown rapidly in recent years. It will grow from$8.76 billion in 2024 to $10.47 billion in 2025 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be attributed to product diversification, advancements in extraction methods, acceptance by healthcare professionals, expansion of retail channels, integration into consumer lifestyles
The CBD nutraceuticals market size is expected to see rapid growth in the next few years. It will grow to $20.37 billion in 2029 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to integration into mainstream wellness, quality control measures, shifting attitudes in healthcare, continued research and development, diversification of product range. Major trends in the forecast period include legalization and regulatory changes, consumer awareness and education, rise in health and wellness consciousness, expansion of product variety, research and development.
The rising demand for plant-based foods is projected to drive the growth of the CBD nutraceuticals market. Herbal supplements, which are dietary supplements derived from the oils, roots, seeds, berries, or flowers of various herbs, are becoming more popular than conventional supplements due to their natural composition and the absence of harmful chemicals. CBD nutraceuticals, obtained from cannabis plants, offer health benefits that go beyond the basic nutritional value of foods. Consequently, the growing interest in plant-based dietary supplements is contributing to an increase in CBD nutraceutical sales. For example, a report from the Good Food Institute, a U.S.-based non-profit organization, indicated that global retail sales of plant-based meat and seafood reached $6.1 billion in 2022, reflecting an 8% revenue growth and a 5% increase in weight. Thus, the heightened demand for plant-based foods is driving the expansion of the CBD nutraceutical market.
Increasing awareness about health and fitness is set to amplify the CBD nutraceutical market. The rising consciousness about holistic well-being, encompassing physical, mental, and social dimensions, creates a conducive environment for CBD nutraceuticals. Consumers actively seek natural solutions for their overall wellness. For example, a Nutrisystem survey in January 2022 revealed that 53% of 2,000 participants aimed to lose an average of 14 pounds in 2022. This heightened awareness of health and fitness is a key driver propelling the CBD nutraceutical market.
Product innovations are a significant trend gaining traction in the CBD nutraceuticals market. Key companies in this sector are prioritizing the development of new products to enhance and maintain their market positions. For example, in August 2024, Curaleaf Holdings Inc., a U.S.-based cannabis company, introduced JAMS Remix, a new line of flavorful jellies designed to cater to the diverse needs of cannabis consumers. These jellies utilize fast-acting onset technology and feature unique multi-cannabinoid ratios along with functional ingredients for targeted effects throughout the day. The product line includes three varieties: Shineapple, which combines THC, THCV, and CBG to provide a motivational boost; Sootheberry, featuring THC, CBD, and L-Theanine for relaxation; and Lullaberry, formulated for nighttime use with THC, CBN, CBD, and melatonin to promote a sense of calm.
Major players in the CBD nutraceutical market are innovating by developing CBD soft gels to cater to larger consumer bases and boost revenue. Irwin Naturals Inc., a U.S.-based nutraceutical company, introduced CBD 25mg Softgels in March 2023. These soft gels allow consumers to seamlessly incorporate premium CBD derived from cannabis into their daily health routines. Irwin Naturals' Cannabis product line offers soft gels crafted with hemp seed oil and medium-chain triglyceride (MCT) oil, presenting different formulations with distinct CBD and THC ratios, aiming to address various wellness needs.
In March 2024, Hempacco Co. Inc., a U.S.-based company specializing in hemp smoking products, acquired Covalent CBD for an undisclosed sum. This acquisition is intended to broaden Hempacco's product range and solidify its standing in the expanding CBD market. By integrating Covalent CBD's expertise in cannabinoid extraction and formulation, Hempacco aims to enhance its lineup of hemp-derived products. Covalent CBD is a U.S.-based company that focuses on premium cannabinoid ingredients and retail-ready finished products.
Major companies operating in the CBD nutraceuticals market include CV Sciences Inc., Elixinol LLC, Medterra CBD, Charlotte's Web Holdings Inc., Diamond CBD Inc., Garden of Life LLC, Green Roads, Isodiol International Inc., Medical Marijuana Inc., Cannavedic Pvt. Ltd., Canopy Growth Corporation, Folium Biosciences LLC, Gaia Botanicals LLC, Kats Botanicals Ltd., Medix CBD, Valens Company, Aphria Inc., Hemp Bombs, Cronos Group Inc., GW Pharmaceuticals Group plc, Harvest One Cannabis Inc., The Supreme Cannabis Company, Organigram Holdings Inc., HEXO Corp., Aleafia Health Inc., MediPharm Labs Corp., Joy Organics LLC, Shaman Botanicals LLC, Irwin Naturals Inc., HempFusion Wellness Inc.
North America was the largest region in the CBD nutraceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global CBD nutraceuticals market report forecast period. The regions covered in the cbd nutraceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the cbd nutraceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The CBD (cannabidiol) nutraceuticals market consists of sales of CBD oils, CDB creams for spread, CBD gels, CBD vapes, and CBD baked foods. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
CBD Nutraceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cbd nutraceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cbd nutraceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cbd nutraceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.